Critical care therapeutics: Important changes in the ACLS 2000 guidelines for the management of cardiac arrest

Hospital Pharmacy

Volumn 37, Issue 5, 2002, Pages

  Fraser, Gilles L ^a   Bagwell, Sandra P ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; BRETYLIUM; LIDOCAINE; MAGNESIUM; VASOPRESSIN;

CLINICAL TRIAL; CRITICAL ILLNESS; DRUG CLASSIFICATION; DRUG INDICATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEART ARREST; HEART VENTRICLE FIBRILLATION; HUMAN; INTENSIVE CARE; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; RESUSCITATION; REVIEW; SIDE EFFECT; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036071994     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1177/001857870203700504     Document Type: Review

References (22)

1. Pharmacologic management of arrhythmias in critical care medicine: Interpreting the new ACLS guidelines
2. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care: An international consensus on science
3. Answers and insights about application of guidelines 2000 for CPR and ECC
4. The next chapter in the high-dose epinephrine story: Unfavorable neurologic outcomes?
5. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital
6. Cumulative epinephrine dose during cardiopulmonary resuscitation and neurologic outcome
7. Use of epinephrine as vasopressor agent during cardiopulmonary resuscitation: Another example of a double-edged sword
8. Use of pressors in the treatment of cardiac arrest
9. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care
10. Randomized comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation
11. Vasopressin versus epinephrine for in-hospital cardiac arrest: A randomized controlled trial
12. Vasopressin or epinephrine: Which initial vasopressor for cardiac arrests?
13. Lidocaine in out-of-hospital fibrillations: Does it improve survival?
14. Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation
15. Reconsideration of the routine and preferential use of lidocaine in the emergent treatment of ventricular arrhythmias
16. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation
17. ISIS-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
18. Effects of intravenous magnesium in suspected acute myocardial infarction: Overview of randomized trials
19. Intravenous magnesium sulphate in suspected acute myocardial infarction: Results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)
20. Randomised trial of magnesium in in-hospital cardiac arrest
21. Magnesium in cardiac arrest (the magic trial)
22. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation